Bandelow, B., and Michaelis, S. “Epidemiology of Anxiety Disorders in the 21st Century.” Dialogues Clin Neurosci 17 (2015): 327–35.
American College Health Association. American College Health Association-National College Health Assessment II: Undergraduate Student Reference Group Executive Summary Fall 2016. Hanover, MD: American College Health Association, 2017.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing; 2013.
Coplan, J. D., et al. “The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism.” Front Evol Neurosci 3, no. 8 (2011). https://doiorg/10.3389/fnevo.2011.00008.
Huffman, J. C., et al. “Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.” Prim Care Companion J Clin Psychiatry 4 (2002): 54–62.
Jacka, F. N., et al. “Association of Western and Traditional Diets with Depression and Anxiety in Women.” Am J Psychiatry 167 (2010): 305–11.
Katerndahl, D. A. “Chest Pain and Its Importance in Patients with Panic Disorder: An Updated Literature Review.” Prim Care Companion J Clin Psychiatry 10 (2008): 376–83.
Krusemark, E. A., and Li, W. “Enhanced Olfactory Sensory Perception of Threat in Anxiety: An Event-Related fMRI Study.” Chemosensory Perception 5 (2012): 37–45.
Llewellyn, N., et al. “Reframing Thoughts to Reduce Anxiety: Reappraisal and Suppression Mediate the Contribution of Regulatory Focus to Anxiety in Healthy Adults.” Emotion 13 (2013): 610–15.
National Institute of Mental Health. https://www.nimh.nih.gov/health/statistics/.
Penney, A. M., et al. “Intelligence and Emotional Disorders: Is the Worrying and Ruminating Mind a More Intelligent Mind?” Personality and Individual Differences 74 (2015): 90–93.
Schonfeld, W. H., et al. “The Functioning and Well-Being of Patients with Unrecognized Anxiety Disorders and Major Depressive Disorder.” J Affective Disorders 43 (1997): 105–19.
Andersson, G., et al. “The Use of the Internet in the Treatment of Anxiety Disorders.” Curr Opin Psychiatry 18 (2005): 73–77.
Broocks, A., et al. “Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder.” Am J Psychiatry 155 (1998): 603–9.
Desai, R., et al. “Effects of Yoga on Brain Waves and Structural Activation: A Review.” Complement Ther Clin Pract 21 (2015): 112–18.
Fiona, S., et al. “International Tables of Glycemic Index and Glycemic Load Values.” Diabetes Care 31 (2008): 2281–83.
Harvard Health Publications; Harvard Medical School. Harvard Heart Letter, March 17, 2017. http://www.health.harvard.edu/diet-and-weight-loss/calories-burned-in-30-minutes-of-leisure-and-routine-activities.
Hirai, M., and Clum, G. A. “A Meta-analytic Study of Self-Help Interventions for Anxiety Problems.” Behav Ther 37 (2006): 99–111.
Hudson, C., et al. “Protein-Source Tryptophan as an Efficacious Treatment for Social Anxiety Disorder: A Pilot Study.” Can J Physiol Pharmacol 85 (2007): 928–32.
Jacka, F. N, et al. “Association of Western and Traditional Diets with Depression and Anxiety in Women.” Am J Psychiatry 167 (2010): 305–11.
Jorm, A. F., Christensen, H., Griffiths, K. M., Parslow, R. A., Rodgers, B., and Blewitt, K. A. “Effectiveness of Complementary and Self-Help Treatments for Anxiety Disorders.” Supplement, Med J Aust 181, no. S7 (2004): S29–S46.
Kirkwood, G., et al. “Yoga for Anxiety: A Systematic Review of the Research Evidence.” Br J Sports Med 39 (2005): 884–91.
Koszycki, D, et al. “Randomized Trial of a Meditation-Based Stress Reduction Program and Cognitive Behavior Therapy in Generalized Social Anxiety Disorder.” Behav Res Ther 45 (2007): 2518–26.
Last, N., et al. “The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review.” J Alzheimers Dis 56 (2017): 275–86.
Lee, S. H., et al. “Effectiveness of a Meditation-Based Stress Management Program as an Adjunct to Pharmacotherapy in Patients with Anxiety Disorder.” J Psychosom Res 62 (2007): 189–95.
Low Dog, T. “The Role of Nutrition in Mental Health.” Altern Ther Health Med 16 (2010): 42–46.
National Institute for Health and Clinical Excellence. Computerised Cognitive Behaviour Therapy for Depression and Anxiety. Review of Technology Appraisal 51. London: NICE, 2006.
Seabrook, E. M., et al. “Social Networking Sites, Depression, and Anxiety: A Systematic Review.” JMIR Ment Health 3, no. 4 (2016): e50.
Tumur, I., et al. “Computerised Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder: A Systematic Review.” Psychother Psychosom 76 (2007): 196–202.
Wipfli, B. M., et al. “The Anxiolytic Effects of Exercise: A Meta-analysis of Randomized Trials and Dose-Response Analysis.” J Sport Exerc Psychol 30 (2008): 392–410.
Antony, M. M., and Stein, M. B. Oxford Handbook of Anxiety and Related Disorders. Oxford: Oxford University Press, 2008.
A-Tiak, J. G., et al. “A Meta-analysis of the Efficacy of Acceptance and Commitment Therapy for Clinically Relevant Mental and Physical Health Problems.” Psychother Psychosom 84 (2015): 30–36. https://doi.org/10.1159/000365764. Epub ahead of print, Dec. 24, 2014.
Bystritsky, A., et al. “Current Diagnosis and Treatment of Anxiety Disorders.” Pharmacy and Therapeutics 38 (2013): 41–44.
Fredette, C., et al. “Using Hypnosis in the Treatment of Anxiety Disorders: Pros and Cons.” In New Insights into Anxiety Disorders, edited by F. Durbano, 343–77. InTech, 2013. ISBN 978-953-51-1053-8. https://doi.org/10.5772/46003.
Hofmann, S. G., et al. “The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.” Cognitive Therapy and Research 36 (2012): 427–40.
Hofmann, S. T., et al. “The Effect of Mindfulness-Based Therapy on Anxiety and Depression: A Meta-analytic Review.” J Consult Clin Psychol 78 (2010): 169–83.
Swedish Council on Health Technology Assessment. Treatment of Anxiety Disorders: A Systematic Review. SBU Yellow Report No. 171/1+2, November 2005.
Thomaes, K., et al. “Degrading Traumatic Memories with Eye Movements: A Pilot Functional MRI Study in PTSD.” Eur J Psychotraumatol 7 (Nov. 29, 2016): 31371. https://doi.org/10.3402/ejpt.v7.31371. eCollection 2016.
Davidson, J. R., et al. “Homeopathic Treatments in Psychiatry: A Systematic Review of Randomized Placebo-Controlled Studies.” J Clin Psychiatry 72 (2011): 795–805.
D’Urso, G., et al. “Transcranial Direct Current Stimulation for Obsessive-Compulsive Disorder: A Randomized, Controlled, Partial Cover Trial.” Depress Anxiety 33 (2016): 1132–40.
Fedotova, J., et al. “Therapeutical Strategies for Anxiety and Anxiety-like Disorders Using Plant-Derived Natural Compounds and Plant Extracts.” Biomed Pharmacother 95 (2017): 437–46.
Field, T. “Massage Therapy Research Review.” Complement Ther Clin Pract 20 (2014): 224–29.
Iannone, A. “Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Appear to Be Safe Neuromodulatory Techniques Useful in the Treatment of Anxiety Disorders and Other Neuropsychiatric Disorders.” Arq Neuropsiquiatr 74 (2016): 829–35.
Joyce, J., and Herbison, G. P. “Reiki for Depression and Anxiety.” Cochrane Database Syst Rev 4 (Apr. 3, 2015): CD006833. https://doi.org/10.1002/14651858.CD006833.pub2.
Kessler, R. C., et al. “The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States.” Am J Psychiatry 158 (2001): 289–94.
Lakhan, S. E., and Vieira, K. F. “Nutritional and Herbal Supplements for Anxiety and Anxiety-Related Disorders: Systematic Review.” Nutrition Journal 9 (2010): 42. http://www.nutritionj.com/c ontent/9/1/42.
Lebowitz, K. R., et al. “Effects of Humor and Laughter on Psychological Functioning, Quality of Life, Health Status, and Pulmonary Functioning among Patients with Chronic Obstructive Pulmonary Disease: A Preliminary Investigation.” Heart Lung 40 (2011): 310–19.
Marzbani, H., et al. “Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications.” Basic Clin Neurosci 7 (2016): 143–58.
Mizrachi Zer-Aviv, T., et al. “Cannabinoids and Post-traumatic Stress Disorder: Clinical and Preclinical Evidence for Treatment and Prevention.” Behav Pharmacol 27 (2016): 561–69.
Pilkington, K. “Acupuncture Therapy for Psychiatric Illness.” Int Rev Neurobiol 111 (2013): 197–216.
Saeed, S. A., Bloch, R. M., and Antonacci, D. J. “Herbal and Dietary Supplements for Treatment of Anxiety Disorders.” American Family Physician 76 (2007): 549–56.
Shin, E. S., et al. “Massage with or without Aromatherapy for Symptom Relief in People with Cancer.” Cochrane Database Syst Rev 6 (June 3, 2016): CD009873. https://doi.org/10.1002/14651858.CD009873.pub3.
Soares, V. P., and Campos, A. C. “Evidences for the Anti-panic Actions of Cannabidiol.” Curr Neuropharmacol 15 (2017): 291–99.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Antony, M. M., and Stein, M. B. Oxford Handbook of Anxiety and Related Disorders. Oxford: Oxford University Press, 2008.
Bystritsky, A., et al. “Current Diagnosis and Treatment of Anxiety Disorders.” Pharmacy and Therapeutics 38 (2013): 41–44.
Newman, M. G., et al. “Worry and Generalized Anxiety Disorder: A Review and Theoretical Synthesis of Evidence on Nature, Etiology, Mechanisms, and Treatment.” Annual Review of Clinical Psychology 9 (2013): 275–97.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Batelaan, N. M., et al. “Evidence-Based Pharmacotherapy of Panic Disorder: An Update.” International Journal of Neuropsychopharmacology 15 (2012): 403–15.
Caldirola, D., et al. “Personalized Medicine in Panic Disorder: Where Are We Now? A Meta-regression Analysis.” Personalized Medicine in Psychiatry 1–2 (2017): 26. https://doi.org/10.1016/j.pmip.2016.12.003.
Kessler, R. C., et al. “The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey Replication.” Arch Gen Psychiatry 63 (2006): 415–24.
Taylor, C. B. “Panic Disorder.” British Medical Journal 332 (2006): 951–55.
Acarturk, C., et al. “Psychological Treatment of Social Anxiety Disorder: A Meta-analysis.” Psychological Medicine 39 (2009): 241–54.
Addolorato, G., et al. “Anxiety and Depression: A Common Feature of Health Care Seeking Patients with Irritable Bowel Syndrome and Food Allergy.” Hepatogastroenterology 45 (1998): 1559–64.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Boraxbekk, C. J., et al. “Neuroplasticity in Response to Cognitive Behavior Therapy for Social Anxiety Disorder.” Translational Psychiatry 6 (Feb. 2016). https://doi.org/10.1038/tp.2015.218.
Furmark, T., et al. “Common Changes in Cerebral Blood Flow in Patients with Social Phobia Treated with Citalopram or Cognitive-Behavioral Therapy.” Arch Gen Psychiatry 59 (2002): 425–33.
Goodwin, R. D. “Association between Physical Activity and Mental Disorders among Adults in the United States.” Prev Med 36 (2003): 698–703.
Jacka, F. N., et al. “Association of Western and Traditional Diets with Depression and Anxiety in Women.” Am J Psychiatry 167 (2010): 305–11.
Jacka, F. N., et al. “The Association between Habitual Diet Quality and the Common Mental Disorders in Community-Dwelling Adults: The Hordaland Health Study.” Psychosom Med 73 (2011): 483–90.
Jayakody, K., et al. “Exercise for Anxiety Disorders: Systematic Review.” Br J Sports Med 43 (2014): 187–96.
Kushnir, J., et al. “The Link between Social Anxiety Disorder, Treatment Outcome, and Sleep Difficulties among Patients Receiving Cognitive Behavioural Group Therapy.” Sleep Med 15 (2014): 515–21.
Nordahl, H. M., et al. “Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial.” Psychother Psychosom 85, no. 6 (2016): 346. https://doi.org/10.1159/000447013.
Ossman, W. A., Wilson, K. G., Storaasli, R. D., and McNeill, J. W. “A Preliminary Investigation of the Use of Acceptance and Commitment Therapy in Group Treatment for Social Phobia.” Rev Int Psicol Ter Psicol 6 (2006): 397–416.
Powers, M., et al. “A Meta-analytic Review of Psychological Treatments for Social Anxiety Disorder.” International Journal of Cognitive Therapy 1 (2008): 94–113.
Roy-Byrne, P. P., et al. “Pharmacological Treatments for Panic Disorder, Generalized Anxiety Disorder, Specific Phobia, and Social Anxiety Disorder.” In A Guide to Treatments That Work, 3rd ed., edited by P. E. Nathan and J. M. Gorman, 395–430. New York: Oxford University Press, 2007.
Zalta, A. K., et al. “Sleep Quality Predicts Treatment Outcome in CBT for Social Anxiety Disorder.” Depress Anxiety 30 (2013): 1114–20.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Costa, R. T. D., et al. “Virtual Reality Exposure Therapy for Fear of Driving: Analysis of Clinical Characteristics, Physiological Response, and Sense of Presence.” Rev Bras Psiquiatr (Feb. 15, 2018). https://doi.org/10.1590/1516-4446-2017-2270. Epub ahead of print.
Gujjar, K. R., et al. “Virtual Reality Exposure Therapy for Treatment of Dental Phobia.” Dent Update 44 (2017): 423–24, 427–28, 431–32, 435.
Kessler, R. C., et al. “Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R).” Arch Gen Psychiatry 62 (2005): 593–602.
Linares, I. M. P., et al. “Neuroimaging in Specific Phobia Disorder: A Systematic Review of the Literature.” Rev Bras Psiquiatr 34 (2012): 101–11.
Öst, L. G. “One-Session Treatment for Specific Phobias.” Behaviour Research and Therapy 27 (1989): 1–7.
Sarris, J., et al. “Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence.” Evid Based-Complement Alternat Med 2012 (2012): 809653. https://doi.org/10.1155/2012/809653.
Wolitzky-Taylor, K. B., et al. “Psychological Approaches in the Treatment of Specific Phobias: A Meta-analysis.” Clinical Psychology Review 28 (2008): 1021–37.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Chamberlain, S. R., et al. “Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives.” Science 321 (2008): 421–22.
Fineberg, N. A., et al. “Evidence-Based Pharmacotherapy of Obsessive-Compulsive Disorder.” Intl J Neuropsychopharm 15 (2012): 1173–91.
Goodman, W. K., et al. “The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part 1. Development, Use and Reliability.” Arch Gen Psychiatry 46 (1989): 1006–11.
Kobak, K. A., et al. “St John’s Wort versus Placebo in Obsessive-Compulsive Disorder: Results from a Double-Blind Study.” Int Clin Psychopharmacol 20 (2005): 299–304.
Lack, C. W. “Obsessive-Compulsive Disorder: Evidence-Based Treatments and Future Directions for Research.” World J Psychiatry 2 (2012): 86–90.
Pepper, J., et al. “Deep Brain Stimulation versus Anterior Capsulotomy for Obsessive-Compulsive Disorder: A Review of the Literature.” J Neurosurg 122 (2015): 1028–37.
Perani, D., et al. “[18F]FDG PET Study in Obsessive-Compulsive Disorder: A Clinical/Metabolic Correlation Study after Treatment.” Br J Psychiatry 166 (1995): 244–50.
Ravindran, A. V., and da Silva, T. L. “Complementary and Alternative Therapies as Add-on to Pharmacotherapy for Mood and Anxiety Disorders: A Systematic Review.” J Affect Disord 150 (2013): 707–19.
Sugarman, M. A., et al. “Obsessive-Compulsive Disorder Has a Reduced Placebo (and Antidepressant) Response Compared to Other Anxiety Disorders: A Meta-analysis.” J Affect Disord 218 (2017): 217–26.